Massachusetts Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 31 (84% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 19,643
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 72.35%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 1,111
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 74.69%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 22.62% 21.78%
White, Hispanic/Latino Patients 19.58% 27.99%
Black/African American, Non-Hispanic/Latino Patients 16.50% 13.32%
Black/African American, Hispanic/Latino Patients 6.33% 6.48%
Asian Patients3 3.98% 3.24%
American Indian/Alaska Native Patients3 0.32% 0.09%
Native Hawaiian/Other Pacific Islander Patients3 0.54% 0.63%
Patients with More than one race3 2.84% 2.61%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 9.10% 9.90%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 6.38% 4.86%
Unreported/Refused to Report Race and Ethnicity 11.80% 9.09%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 3,620
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 84.28%
COVID-19 Immunization Series Completed 4,144
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 76.50%
COVID-19 Immunization Series Additional 1,978
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 35.72%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 13.76% 20.54% 58.49%
White, Hispanic/Latino Patients 17.76% 18.85% 3.99%
Black/African American, Non-Hispanic/Latino Patients 30.58% 23.75% 11.12%
Black/African American, Hispanic/Latino Patients 5.41% 4.03% 1.31%
Asian Patients3 2.07% 3.16% 6.77%
American Indian/Alaska Native Patients3 0.36% 0.36% 0.35%
Native Hawaiian/Other Pacific Islander Patients3 0.72% 0.84% 0.30%
Patients with More than one race3 3.43% 3.04% 2.22%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 13.43% 12.81% 6.42%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 5.52% 6.20% 4.20%
Unreported/Refused to Report Race and Ethnicity 6.96% 6.42% 4.80%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 0.00%
1 to 24 Hours 41.94%
More Than 24 Hours 58.06%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 6.45%
Staffing to administer the vaccine 19.35%
Vaccine confidence 48.39%
Vaccine storage capacity 3.23%
Vaccine supply 6.45%
Other 9.68%
None 35.48%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 35.48%
Average Percent of Health Center Visits Conducted Virtually 33.71%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 41.94%
Number of Mobile Van Sites 25
Number of Pop-up Clinics 25
Number of School-Based Vaccination Sites 7

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 45.16%
None 54.84%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 12.90%
Patient awareness/education 3.23%
Staffing capacity 3.23%
Therapy administration/onsite logistics 29.03%
Other 19.35%
None 45.16%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021